2023-10-04 09:39:02
AURINIA (AUR-VCS_2016-01) – Latin Clinical Trial Center

AURINIA (AUR-VCS_2016-01)

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis

Join the discussion 6 Comments

Leave a Reply